Overall market sentiment has been high on ProQR Therapeutics NV (PRQR) stock lately. PRQR receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With PRQR Stock Today?
ProQR Therapeutics NV (PRQR) stock is trading at $5.32 as of 2:31 PM on Monday, Feb 8, a gain of $0.32, or 6.4% from the previous closing price of $5.00. The stock has traded between $4.91 and $5.35 so far today. Volume today is 768,277 compared to average volume of 883,280.
To screen for more stocks like ProQR Therapeutics NV click here.
More About ProQR Therapeutics NV
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.
Click Here to get the full Stock Score Report on ProQR Therapeutics NV (PRQR) Stock.
